Dr.
William Heyward had spent almost three decades of his life fighting some of the world’s deadliest communicable diseases, such as
HIV/AIDS, Ebola, haemophilus influenzae, hepatitis B, and hepatic cancer. He had made researches on the causes, effects and prevention of these diseases.
His works brought him to far-flung places and world’s poorest areas.
When he joined CDC in 1979, he worked with the indigenous populations of Anchorage, Alaska (his first assignment) for almost ten years. He practically eradicated the diseases of Hepatitis B, liver cancer and haemophilus influenzae among Alaskan natives.
In 1988, her rejoined CDC in Atlanta and organized the International AIDS program. He led the epidemiological studies of HIV/AIDS in Brazil, Honduras, Zaire (now Congo), Guinea Bissau, Burkina Faso, Ivory Coast, and Thailand. Then, he developed CDC field stations for the study of HIV/AIDS in Ivory Coast and Thailand. In the next twelve years, his mission against AIDS would pair him with the World Health Organization in Zaire, Rwanda, Uganda, Thailand, and Brazil. He also assisted investigate the Ebola epidemic in Zaire.
He retired from the CDC in 2000 but was appointed V. P. for International Clinical Research with VaxGen, Inc. Thereat, he worked on trials for an HIV vaccine for Thailand, the U.S., Canada, and Europe. He also assisted the Walter Reed Army Institute for Research in developing plans for a “prime-boost” vaccination strategy with the canary pox vaccine.
After he left VaxGen in January 2004, he became consultant to the International AIDS Vaccine Initiative and the Ministry of Health in Brazil. In April 2004, he formed Quattro Clinical Research (QCR), a Clinical Research Organization consulting with many bio-tech and pharmaceutical companies on infectious diseases, including HIV/AIDS and meningococcal vaccines, allergy vaccines, vaginal microbicides for the prevention of HIV infection in women of developing countries, and cancer compounds.
No comments:
Post a Comment